Search

Your search keyword '"Braunwald, Eugene"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Braunwald, Eugene" Remove constraint Author: "Braunwald, Eugene" Publication Year Range This year Remove constraint Publication Year Range: This year
36 results on '"Braunwald, Eugene"'

Search Results

2. Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

4. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

7. Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

9. Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial

11. Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial

15. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

16. Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis

17. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations

18. Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists:insight from the PARADISE MI trial

19. Pulmonary Congestion and Left Ventricular Dysfunction after Myocardial Infarction:Insights from the PARADISE-MI Trial

20. Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation.

21. Cardiovascular effects of climate change.

22. Two cardiac myosin inhibitors in the treatment of obstructive hypertrophic cardiomyopathy

23. Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61.

25. Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.

26. Triglycerides: the past, the present, and the future.

28. SHOULD FRAIL ELDERLY AF PATIENTS ON VKA SWITCH TO A DOAC? A RANDOMIZED COMPARISON FROM COMBINE-AF, A PATIENT-LEVEL METANALYSIS OF THE 4 LARGE RCTS OF DOACS VS WARFARIN

29. CONCURRENT EVALUATION OF HSTNI AND HSTNT AND THEIR ASSOCIATIONS WITH CARDIOVASCULAR EVENTS IN 37,886 PATIENTS WITH STABLE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

30. IN-HOSPITAL OR OUT-OF-HOSPITAL INITIATION OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN IN PATIENTS WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION AFTER A WORSENING HEART FAILURE EVENT: THE PARAGLIDE-HF TRIAL

32. Foreword

34. Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations

35. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.

Catalog

Books, media, physical & digital resources